Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities) is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities) has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Microsatellite Stable Rectal Carcinoma, Locally Advanced Rectal Adenocarcinoma, Adenocarcinoma of the Rectum.
Sponsors: Memorial Sloan Kettering Cancer Center.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities) has 2 clinical trials on record, with 2 currently active. Their work covers Microsatellite Stable Rectal Carcinoma, Locally Advanced Rectal Adenocarcinoma, Adenocarcinoma of the Rectum.
Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.